Access to anti-retroviral drugs, male in Sierra Leone

Sierra Leone: Access to anti-retroviral drugs, male was 82.0% in 2024. ◆ Volatile

Latest (2024)
82.0%
Change on year
up 26.2%
World rank
42nd
of 141 countries
All-time high
82.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Sierra Leone, 2000–2024

0204060802000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 1 %2006: 1 %2007: 2 %2008: 4 %2009: 7 %2010: 10 %2011: 13 %2012: 9 %2013: 9 %2014: 10 %2015: 15 %2016: 18 %2017: 22 %2018: 28 %2019: 33 %2020: 36 %2021: 45 %2022: 56 %2023: 65 %2024: 82 %

Source: UNAIDS estimates. Measured in %.

Analysis

Sierra Leone recorded 82.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.

The figure is up 26.2% on the previous year and up 720.0% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Sierra Leone peaked at 82.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Sierra Leone 42nd out of 141 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Sierra Leone, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Sierra Leone, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 1.0%
2006 1.0% +0.0%
2007 2.0% +100.0%
2008 4.0% +100.0%
2009 7.0% +75.0%
2010 10.0% +42.9%
2011 13.0% +30.0%
2012 9.0% -30.8%
2013 9.0% +0.0%
2014 10.0% +11.1%
2015 15.0% +50.0%
2016 18.0% +20.0%
2017 22.0% +22.2%
2018 28.0% +27.3%
2019 33.0% +17.9%
2020 36.0% +9.1%
2021 45.0% +25.0%
2022 56.0% +24.4%
2023 65.0% +16.1%
2024 82.0% +26.2%

Averages by decade

DecadeAverage LowestHighest Years
2000s 1.5% 0.0% 7.0% 10
2010s 16.7% 9.0% 33.0% 10
2020s 56.8% 36.0% 82.0% 5

Countries ranked near Sierra Leone

  1. 40 Luxembourg 83.0% compare
  2. 40 Tanzania, United Republic of 83.0% compare
  3. 42 Guatemala 82.0% compare
  4. 42 Mozambique 82.0% compare
  5. 42 Portugal 82.0% compare

See the full ranking of 160 places →

More gender data for Sierra Leone

All data for Sierra Leone →

Frequently asked questions

What is access to anti-retroviral drugs, male in Sierra Leone?
Access to anti-retroviral drugs, male in Sierra Leone was 82.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Sierra Leone?
The highest recorded value was 82.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Sierra Leone?
The lowest recorded value was 0.0% in 2000.
How does Sierra Leone rank for access to anti-retroviral drugs, male?
Sierra Leone ranks 42nd out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Sierra Leone?
Over the last ten years it is up 720.0%. The long-run trend across the full record is volatile.
Where does this Sierra Leone data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Sierra Leone. Statizoid, drawing on UNAIDS estimates. Retrieved 10 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/sierra-leone/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/sierra-leone/">Access to anti-retroviral drugs, male in Sierra Leone</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.